[Vaccination programmes].
Identifieur interne : 000496 ( Main/Exploration ); précédent : 000495; suivant : 000497[Vaccination programmes].
Auteurs : M Carmen Varela [Espagne]Source :
- Revista espanola de salud publica [ 1135-5727 ]
Descripteurs français
- KwdFr :
- MESH :
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- MESH :
- chemical : Viral Vaccines.
- geographic : Spain.
- Humans, Vaccination.
Abstract
Immunization is a highly cost-effective intervention that saves many lives. Its objective is to control and eliminate vaccine-preventable diseases (when the characteristics of the disease and the vaccine make it possible), resulting in improvements in the health of the population. In Spain, the first vaccination schedule was introduced in 1975 and currently coverages > 95% are achieved in children aged < 2 years of age. Before deciding to introduce a vaccination programme in a community or country, a series of aspects should be considered, including the disease burden in the population, the effectiveness and safety of the vaccine, the changes in the dynamics of the infection when the vaccine is introduced, the cost-effectiveness of the vaccine, the theoretical potential of elimination/eradication of the disease and the existence of other preventive or therapeutic measures. Once the programme has been introduced it should be subject to evaluation, considering aspects such as the coverage, effectiveness, safety and the impact on the population. This work defines different vaccination strategies for three diseases for which efficacious and safe vaccines are available: hepatitis A, influenza and varicella.
DOI: 10.1590/s1135-57272009000500005
PubMed: 20111812
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Vaccination programmes].</title><author><name sortKey="Varela, M Carmen" sort="Varela, M Carmen" uniqKey="Varela M" first="M Carmen" last="Varela">M Carmen Varela</name><affiliation wicri:level="3"><nlm:affiliation>Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009 Sep-Oct</date><idno type="RBID">pubmed:20111812</idno><idno type="pmid">20111812</idno><idno type="doi">10.1590/s1135-57272009000500005</idno><idno type="wicri:Area/Main/Corpus">00486</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00486</idno><idno type="wicri:Area/Main/Curation">000486</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000486</idno><idno type="wicri:Area/Main/Exploration">000486</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Vaccination programmes].</title><author><name sortKey="Varela, M Carmen" sort="Varela, M Carmen" uniqKey="Varela M" first="M Carmen" last="Varela">M Carmen Varela</name><affiliation wicri:level="3"><nlm:affiliation>Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author></analytic><series><title level="j">Revista espanola de salud publica</title><idno type="ISSN">1135-5727</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans (MeSH)</term><term>Spain (MeSH)</term><term>Vaccination (MeSH)</term><term>Viral Vaccines (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Espagne (MeSH)</term><term>Humains (MeSH)</term><term>Vaccination (MeSH)</term><term>Vaccins antiviraux (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Espagne</term><term>Humains</term><term>Vaccination</term><term>Vaccins antiviraux</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Immunization is a highly cost-effective intervention that saves many lives. Its objective is to control and eliminate vaccine-preventable diseases (when the characteristics of the disease and the vaccine make it possible), resulting in improvements in the health of the population. In Spain, the first vaccination schedule was introduced in 1975 and currently coverages > 95% are achieved in children aged < 2 years of age. Before deciding to introduce a vaccination programme in a community or country, a series of aspects should be considered, including the disease burden in the population, the effectiveness and safety of the vaccine, the changes in the dynamics of the infection when the vaccine is introduced, the cost-effectiveness of the vaccine, the theoretical potential of elimination/eradication of the disease and the existence of other preventive or therapeutic measures. Once the programme has been introduced it should be subject to evaluation, considering aspects such as the coverage, effectiveness, safety and the impact on the population. This work defines different vaccination strategies for three diseases for which efficacious and safe vaccines are available: hepatitis A, influenza and varicella.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20111812</PMID><DateCompleted><Year>2010</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1135-5727</ISSN><JournalIssue CitedMedium="Print"><Volume>83</Volume><Issue>5</Issue><PubDate><MedlineDate>2009 Sep-Oct</MedlineDate></PubDate></JournalIssue><Title>Revista espanola de salud publica</Title><ISOAbbreviation>Rev. Esp. Salud Publica</ISOAbbreviation></Journal><ArticleTitle>[Vaccination programmes].</ArticleTitle><Pagination><MedlinePgn>639-43</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1135-57272009000500005</ELocationID><Abstract><AbstractText>Immunization is a highly cost-effective intervention that saves many lives. Its objective is to control and eliminate vaccine-preventable diseases (when the characteristics of the disease and the vaccine make it possible), resulting in improvements in the health of the population. In Spain, the first vaccination schedule was introduced in 1975 and currently coverages > 95% are achieved in children aged < 2 years of age. Before deciding to introduce a vaccination programme in a community or country, a series of aspects should be considered, including the disease burden in the population, the effectiveness and safety of the vaccine, the changes in the dynamics of the infection when the vaccine is introduced, the cost-effectiveness of the vaccine, the theoretical potential of elimination/eradication of the disease and the existence of other preventive or therapeutic measures. Once the programme has been introduced it should be subject to evaluation, considering aspects such as the coverage, effectiveness, safety and the impact on the population. This work defines different vaccination strategies for three diseases for which efficacious and safe vaccines are available: hepatitis A, influenza and varicella.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varela</LastName><ForeName>M Carmen</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Programas de vacunación.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Salud Publica</MedlineTA><NlmUniqueID>9600212</NlmUniqueID><ISSNLinking>1135-5727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20111812</ArticleId><ArticleId IdType="pii">S1135-57272009000500005</ArticleId><ArticleId IdType="doi">10.1590/s1135-57272009000500005</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Varela, M Carmen" sort="Varela, M Carmen" uniqKey="Varela M" first="M Carmen" last="Varela">M Carmen Varela</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000496 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000496 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20111812
|texte= [Vaccination programmes].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20111812" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |